|Cancer Research Wire|
Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.
Pathology labs mounted on chips are set to revolutionize the detection and treatment of cancer by using devices as thin as a human hair to analyze bodily fluids. The technology, known as microfluidics, promises portable, cheap devices that could enab...
– American Institute of Physics (AIP)
Biomicrofluidics Embargo expired on 23-Jul-2019 at 11:00 ET
Using single-molecule imaging, researchers witness how molecules find and fix damaged DNA
– Health Sciences at the University of Pittsburgh
Nature Structural and Molecular Biology; R01ES019566, R01ES028686, R33ES025606, P30CA047904, R01CA067985, 1ZIAES050158, 1ZIAES050159, T32GM088119 Embargo expired on 22-Jul-2019 at 11:00 ET
Using an ultra-sensitive and high-throughput isolation technology, UCLA researchers were able to characterize and identify the neoantigens driving the antitumor responses in a patient treated with anti-PD-1 blockade and isolate the T cell receptors r...
– University of California, Los Angeles (UCLA), Health Sciences
American Associate of Cancer Research special conference Embargo expired on 22-Jul-2019 at 08:00 ET
Known as two of the most lethal cancers, ovarian and pancreatic cancer are often called silent killers. As a result, they frequently go undetected until they’re too late to effectively treat. Cancer scientists at Houston Methodist have been vigilan...
– Houston Methodist
Clinical Cancer Research, July 2019 Embargo expired on 22-Jul-2019 at 10:00 ET
Discovery shows how difficult-to-treat prostate cancer evades immune system and reports pre-clinical development of novel treatment and potential for combination use with immunotherapy drugs.
– University of Texas M. D. Anderson Cancer Center
Cancer Cell Embargo expired on 18-Jul-2019 at 11:00 ET
A team at Fred Hutchinson Cancer Research Center has identified a gene that could make immunotherapy treatments, specifically checkpoint inhibitors, work for a wider variety of cancer patients.
– Fred Hutchinson Cancer Research Center
Developmental Cell Embargo expired on 18-Jul-2019 at 11:00 ET
Many women find themselves skipping scientific conferences because of family obligations, a new study finds. Women were less likely than men to attend scientific meetings, although both genders noted that conferences were important to career advancem...
– Michigan Medicine - University of Michigan
JAMA Oncology Embargo expired on 18-Jul-2019 at 11:00 ET
In a study using yeast cells and data from cancer cell lines, Johns Hopkins University scientists report they have found a potential weak spot among cancer cells that have extra sets of chromosomes, the structures that carry genetic material. The vul...
– Johns Hopkins Medicine
Nature; R35-GM118172, R01-HG006677, R01-GM114675, U54-CA210173, 16YOUN21
The results, published July 22 in Nature Medicine, are the latest findings by VICC researchers chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies. The research...
– Vanderbilt University Medical Center
A new study using a special type of electron microscope using samples cooled to extremely cold temperatures provides critical information for drug developers seeking to reduce nausea and vomiting side effects of cancer treatments.
– Case Western Reserve University
New research in JNCCN from the Hutchinson Institute for Cancer Outcomes Research (HICOR) within the Fred Hutch/University of Washington Cancer Consortium—part of the Seattle Cancer Care Alliance—identifies a simple way to help cancer doctors cari...
– National Comprehensive Cancer Network® (NCCN®)
JNCCN—Journal of the National Comprehensive Cancer Network
Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to ...
– Memorial Sloan Kettering Cancer Center
Researchers at Beth Israel Deaconess Medical Center (BIDMC) embarked on a study to investigate whether early changes in energy-related metabolites in the blood – measured shortly after chemotherapy – could be used to identify patients who develop...
– Beth Israel Deaconess Medical Center
Journal of Cardiovascular Translational Research
In a study published in Scientific Reports, first author Yamicia D. Connor, MD, PhD, a resident in the Department of Obstetrics and Gynecology at Beth Israel Deaconess Medical Center (BIDMC), and colleagues, reveal that unlike non-metastatic cells, b...
– Beth Israel Deaconess Medical Center
Scientific Reports; W81XWH-07-1-0482; W81XWH-09-1-0700; BC132168; UL1 TR001102; 1R01CA135242-01A2; CA229772; CA214411; CA236702; T32GM007753...
Rutgers researchers have created a device that can determine whether targeted chemotherapy drugs are working on individual cancer patients. The portable device, which uses artificial intelligence and biosensors, is up to 95.9 percent accurate in coun...
– Rutgers University-New Brunswick
Microsystems & Nanoengineering; Rutgers Today
A new University at Buffalo-led study describes how researchers wirelessly controlled FGFR1 — a gene that plays a key role in how humans grow from embryos to adults — in lab-grown brain tissue.
The ability to manipulate the gene, the study’s...
– University at Buffalo
Proceedings of IEEE
The Coriell Institute for Medical Research is now participating in a prestigious SU2C Catalyst® grant from Stand Up To Cancer for the study of epigenetic therapy in treating urothelial cancer, a common form of cancer typically found in the bladder. ...
– Coriell Institute for Medical Research
More than $2 million in grants recently awarded to a Rutgers Cancer Institute of New Jersey resident researcher will support examination of potential treatment targets for T-cell acute lymphoblastic leukemia (T-ALL).
– Rutgers Cancer Institute of New Jersey
Dr. Phil Evans was honored with National Breast Cancer Foundation's Lifetime Achievement Award.
– UT Southwestern Medical Center